Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 22, 2021 - Issue 7-8
Submit an article Journal homepage
1,745
Views
0
CrossRef citations to date
0
Altmetric
Clinical

Noninvasive ventilation use by patients enrolled in VITALITY-ALS

Stacy A. Rudnicki1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  Correspondence[email protected]
View further author information
,
Jinsy A. Andrews2 The Eleanor and Lou Gehrig ALS Center, The Neurological Institute, New York, NY, USAView further author information
,
Amy Bian1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  View further author information
,
Bettina M. Cockroft1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  View further author information
,
Merit E. Cudkowicz3 Department of Neurology, Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Orla Hardiman4 Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, IrelandView further author information
,
Fady I. Malik1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  View further author information
,
Lisa Meng1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  View further author information
,
Andrew A. Wolff1 Clinical Research and Development, Cytokinetics, Inc, South San Francisco, CA, USA,  View further author information
,
Jeremy M. Shefner5 St. Joseph's Hospital and Medical Cente, Barrow Neurological Institute, Phoenix, AZ, USAView further author information
& ON BEHALF OF THE VITALITY-ALS STUDY GROUP show all
Pages 486-494 | Received 26 Jun 2020, Accepted 25 Feb 2021, Published online: 01 Apr 2021

References

  • Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
  • Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry. 2009;80:84–7.
  • Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
  • Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006;253:1428–36.
  • Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7:217–20.
  • Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155:401–8.
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140–7.
  • Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82–8.
  • Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2005;32:808–11.
  • Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65:1774–7.
  • Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
  • National Institute for Health and Care Excellence (NICE). Motor neuone disease: assessment and management. NICE Guideline [NG42]. 2019. https://www.nice.org.uk/guidance/ng42. Accessed January 15, 2020.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–33.
  • ResMed. Respiratory assist device (RAD) coverage guidelines. 2019. https://www.resmed.com/us/dam/documents/articles/1010293_RAD_Guidelines.pdf. Accessed January 15, 2020.
  • Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, et al. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0:1–594.
  • Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, Genge A, Hardiman O, Jackson CE, et al. Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:331–41.
  • Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61:171–7.
  • Berlowitz DJ, Howard ME, Fiore JF, Jr., Vander Hoorn S, O'Donoghue FJ, Westlake J, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry. 2016;87:280–6.
  • Vitacca M, Montini A, Lunetta C, Banfi P, Bertella E, De Mattia E, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:556–e533.
  • Thakore NJ, Lapin BR, Pioro EP, Aboussouan LS. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology. 2019;93:e306–e316.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.